TUMOR BUDDING IN COLORECTAL CANCER
|
|
- Megan Atkins
- 7 years ago
- Views:
Transcription
1 TUMOR BUDDING IN COLORECTAL CANCER CLINICAL APPROACH Prof. A. Lugli, MD Division of Clinical Pathology University of Bern Symposium de Gastroentérologie Aurigen Lausanne, April 10 th 2014
2 CONTENT BIOLOGY OF TUMOR BUDDING PROGNOSTIC AND PREDICTIVE IMPACT SURGICAL PATHOLOGY OF TUMOR BUDDING CONCLUSION
3 THE IMPORTANCE OF TUMOR MICROENVIRONMENT Hanahan and Weinberg, Cell 2011
4 THE TUMOR MICROENVIRONMENT Hanahan and Weinberg. Cell 2011
5 TUMOR BUDS Definition Single tumor cells or cluster up to 5 tumor cells at the invasive margin EMT like cells Transformation to a motile and invasive phenotype Low proliferation Potentially malignant stem cells
6 TUMOR BUDS Phenotype MUC1 p16 b-cat E-Cad
7 TUMOR BUDS Low proliferation Dawson et al, Histopathology 2014
8 TUMOR BUDS Stem cell character? Hostettler et al, WJG 2010
9 TUMOR BUDS CREED CRC s special force Detachment Loss of E-Cadherin Stroma migration MMP-2, MMP-9 Activated wnt Nuclear b-catenin Angiogenesis & vessel affinity VEGF, CXC3&4 Low proliferation Loss of Ki-67 Stem cell like CD133, ABCG5 Zlobec & Lugli, Oncotarget 2010
10 Zlobec & Lugli. Oncotarget 2010
11 CONTENT BIOLOGY OF TUMOR BUDDING PROGNOSTIC AND PREDICTIVE IMPACT SURGICAL PATHOLOGY OF TUMOR BUDDING CONCLUSION
12 TUMOR BUDDING AND PROGNOSIS A marker of tumor progression Lymph node metastasis Ueno et al. Gastroenterology 2004 Kazama et al. Br J Cancer 2006 Distant metastasis Nakamura et al. DCR 2008 Prall et al. Histopathology 2005 Lymphovascular invasion Lugli et al. Br J Cancer 2009 Ishikawa et al. Cancer 2008 Local recurrence Tanaka et al. DCR 2003 Guzinska-Ustimowicz. AntiC Research 2005
13 TUMOR BUDDING AND PROGNOSIS Independent of the applied scoring system Authors Journal Sample Size CRC Stage Prognostic factor Morodomi et al. Cancer I - IV Yes Hase et al. Dis C&R I - IV Yes Ueno et al. Histopathology I - IV Yes Ueno et al. Cancer 437 I - IV Yes Jass et al. J Clin Pathol I - IV Yes Okuyama et al. J Surg Oncol II / III Yes Okuyama et al. Dis C&R II / III Yes Park et al. Dis C&R I - IV Yes Prall et al. Histopathology I / II Yes Hörkkö et al. Eur J Cancer I - IV Yes Shinto et al. Dis C&R II / III Yes Masaki et al. J Gastro & Hepatol I Yes Choi et al. Int J Colorectal Dis III Yes Konazawa et al. Colorect Diss I - IV Yes Nakamura et al. Dis C&R II Yes Ohtsuki et al. Anticancer Res I - IV Yes Wang et al. Am J Surg Pathol II Yes Lugli et al. Br J Cancer I - IV Yes Sy et al. Dis C&R III No
14 TUMOR BUDDING AND PROGNOSIS UICC Classification Prognostic Factor Tumor-related Host-related Environment related Essential T category N category M category Venous/lymphatic invasion Obstruction Quality of surgery Quality of TME (rectal cancer) Additional Grade, tumor budding, border configuration, perineural invasion, medullary type, CEA, perforation Thrombocytosis Diabetes mellitus Number of lymph nodes in resection specimen New and promising MSI LOH 18q status P53 DNA ploidy TGFbeta1 type II Thymidylate synthase polymorphism VEGF expression 20q copy number, Karyotype Proliferation rate, Metalloproteinase expression, Gene expression profiles Compton C. Prognostic Factors in colorectal cancer edited by Gospodarowicz, O Sullivan and Sobin, 3 rd edition, 2006
15 TUMOR BUDDING AND PROGNOSIS WHO Classification
16 PREDICTIVE VALUE OF TUMOR BUDDING Anti-EGFR therapy Zlobec et al, WJG 2010
17 CONTENT BIOLOGY OF TUMOR BUDDING PROGNOSTIC AND PREDICTIVE IMPACT SURGICAL PATHOLOGY OF TUMOR BUDDING CONCLUSION
18 TUMOR BUDDING Scoring system 10 HPF Method Horcic et al, Hum Pathol 2011
19 TUMOR BUDDING 10 HPF Method Horcic et al, Hum Pathol 2011
20 TUMOR BUDDING Validation of the 10 HPF Method Karamitopoulou et al, Mod Pathol 2012
21 ITB AND PTB pt1 CRC Ueno et al, Gastroenterology 2004
22 PERITUMORAL BUDDING (PTB) Resections Stage II CRC n = 128 T3N0M0 Wang et al, Am J Surg Pathol 2009
23 INTRATUMORAL BUDDING (ITB) Concept: 2 independent cohorts: n=289 and 222 Intratumoural Budding (ITB) + Peritumoural Budding PTB) = Overall Tumour Budding (OTB) Lugli et al, Human Pathol 2011
24 INTRATUMORAL BUDDING (ITB) 1 HPF Method Zlobec et al, BJC 2013
25 INTRATUMORAL BUDDING (ITB) Preoperative biopsies
26 CONTENT BIOLOGY OF TUMOR BUDDING PROGNOSTIC AND PREDICTIVE IMPACT SURGICAL PATHOLOGY OF TUMOR BUDDING CONCLUSION
27 POINTS TO CONSIDER Tumor budding is an independent adverese prognostic factor ITB has to be distinguished from PTB A standardized scoring system is important, but not mandatory The fields of action may include stage II CRC, pt1 CRC and preoperative biopsies
28
29 THANK YOU FOR YOUR ATTENTION!
CHAPTER 14 STAGING AND REPORTING
CHAPTER 14 STAGING AND REPORTING Staging of Colorectal Cancer refers to the classification of the tumour according to the extent of spread in a manner that has a clinically useful correlation with prognosis.
More informationBridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS
Bridging Techniques What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS Associate Professor of Surgery Assistant Program Director, General Surgery Residency Disclosures
More informationDoes my patient need more therapy after prostate cancer surgery?
Does my patient need more therapy after prostate cancer surgery? Contact the GenomeDx Patient Care Team at: 1.888.792.1601 (toll-free) or e-mail: client.service@genomedx.com Prostate Cancer Classifier
More informationTumor Budding as a Useful Prognostic Marker in T1-Stage Squamous Cell Carcinoma of the Esophagus
2013;108:42 46 Tumor Budding as a Useful Prognostic Marker in T1-Stage Squamous Cell Carcinoma of the Esophagus HITOSHI TERAMOTO, MD, 1 * MASAHIKO KOIKE, MD, PhD, 1 CHIE TANAKA, MD, PhD, 1 SUGURU YAMADA,
More informationEMR Can anyone do this?
EMR Can anyone do this? Norio Fukami, MD University of Colorado Piecemeal resection? 1 Endoscopic mucosal resection (EMR) and Endoscopic submucosal dissection (ESD) Endoscopic removal of premalignant or
More informationPrognostic and Predictive Factors in Oncology. Mustafa Benekli, M.D.
Prognostic and Predictive Factors in Oncology Mustafa Benekli, M.D. NCI Definitions ESMO Course -Essentials of Medical Oncology -Istanbul 2 Prognostic factor: NCI Definition A situation or condition, or
More information9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH
9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH Differentiated thyroid cancer expresses the TSH receptor on the cell membrane and responds to TSH stimulation by increasing
More informationHow to report Upper GI EMR/ESD specimens
Section of Pathology and Tumour Biology How to report Upper GI EMR/ESD specimens Dr.H.Grabsch Warning. Most of the criteria, methodologies, evidence presented in this talk are based on studies in early
More informationPathologic Assessment Of The Breast And Axilla After Preoperative Therapy
Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy W. Fraser Symmans, M.D. Associate Professor of Pathology UT M.D. Anderson Cancer Center Pathologic Complete Response (pcr) Proof
More informationContents. Updated July 2011
- Updated July 2011 Guideline Authors: Todd S. Crocenzi, M.D.; Mark Whiteford, M.D.; Matthew Solhjem, M.D.; Carlo Bifulco, M.D.; Melissa Li, M.D.; Christopher Cai, M.D.; and James Durham, M.D. Contents
More informationChristian Wittekind, M.D. 1 Carolyn C. Compton, M.D., Ph.D. 2 Frederick L. Greene, M.D. 3 Leslie H. Sobin, M.D. 4
2511 COMMUNICATION International Union Against Cancer TNM Prognostic Factors Project Committee and the American Joint Committee on Cancer TNM Process Subcommittee TNM Residual Tumor Classification Revisited
More informationChanges in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain Second Opinion in Breast Pathology Usually requested when a patient is referred
More informationCancerStemCell Markers in Lung Cancers: Proofsof. Reservations. Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany
CancerStemCell Markers in Lung Cancers: Proofsof ConceptsandSome Reservations Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany Lung cancer: highest death rate and poorest patient survival
More informationEffects of Herceptin on circulating tumor cells in HER2 positive early breast cancer
Effects of Herceptin on circulating tumor cells in HER2 positive early breast cancer J.-L. Zhang, Q. Yao, J.-H. Chen,Y. Wang, H. Wang, Q. Fan, R. Ling, J. Yi and L. Wang Xijing Hospital Vascular Endocrine
More informationAnalysis of the colorectal tumor microenvironment using integrative bioinformatic tools
MLECNIK Bernhard & BINDEA Gabriela Analysis of the colorectal tumor microenvironment using integrative bioinformatic tools INSERM U872, Jérôme Galon Team15: Integrative Cancer Immunology Cordeliers Research
More informationLoco-regional Recurrence
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer AGO AGO e. e. V. V. Loco-regional Recurrence Loco-regional Recurrence Version 2002: Brunnert / Simon Versions 2003 2012: Audretsch
More informationColorectal cancer. A guide for journalists on colorectal cancer and its treatment
Colorectal cancer A guide for journalists on colorectal cancer and its treatment Contents Contents 2 3 Section 1: Colorectal cancer 4 i. What is colorectal cancer? 4 ii. Causes and risk factors 4 iii.
More informationChallenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014
Challenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014 Prof. Dr. Chris Verslype, Leuven Prof. Dr. Aurel Perren, Bern Menue Challenges: 1. Gastric NET 2. Appendiceal NET 3. Rectal NET SEER,
More informationUICC World Cancer Congress. Cancer Staging and Quality of Care
UICC World Cancer Congress August 27 30, 2012, Montreal CANCER STAGE: A neglected cornerstone of Cancer Control Cancer Staging and Quality of Care Christian Wittekind Institut für Pathologie UKL 1 Agenda!
More informationOutcome of Early Cervical Carcinoma Treated by Wertheim Hysterectomy with Selective Postoperative Radiotherapy
ORIGINAL ARTICLES 613 Outcome of Early Cervical Carcinoma Treated by Wertheim Hysterectomy with Selective Postoperative Radiotherapy S K Tay,*FAMS, MD, FRCOG, L K Tan,**MBBS, M Med (O & G), MRCOG Abstract
More informationA912: Kidney, Renal cell carcinoma
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
More informationTreatment and Surveillance of Non- Muscle Invasive Bladder Cancer
Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer David Josephson, MD FACS Fellowship Director, Urologic Oncology and Robotic Surgery Program Staging Most important in risk assessment and
More informationChapter 2 Staging of Breast Cancer
Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination
More informationPost-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence
Post- survival in completely resected stage I non-small cell lung cancer with local J-J Hung, 1,2,3 W-H Hsu, 3 C-C Hsieh, 3 B-S Huang, 3 M-H Huang, 3 J-S Liu, 2 Y-C Wu 3 See Editorial, p 185 c A supplementary
More informationThe New International Staging System Lung Cancer
The New International Staging System Lung Cancer Valerie W. Rusch, MD Chief, Thoracic Surgery Memorial Sloan-Kettering Cancer Center Chair, Lung and Esophagus Task Force, American Joint Commission on Cancer
More informationSUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
More informationOBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
More informationBRAF as a prognostic marker in papillary thyroid cancer
12 Congresso Nazionale AME Molecular markers in thyroid cancer: current role in clinical practice BRAF as a prognostic marker in papillary thyroid cancer Dott. ssa Cristina Romei Sezione di Endocrinologia
More informationThe evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS
The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic
More informationNovel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting
/, Advance Publications 2016 Novel histopathologic feature identified through image analysis augments stage II colorectal cancer clinical reporting Peter D Caie 1,2, Ying Zhou 3, Arran K Turnbull 3, Anca
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationDIPARTIMENTO di SCIENZE BIOMEDICHE e BIOTECNOLOGICHE
July 15, 2015 Science editor of World Journal of Gastroenterology Jing Yu Email: j.yu@wjgnet.com Dear Prof. Jing Yu, please find enclosed a revised version of our paper Non-coding landscapes of Colorectal
More informationCancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
More informationRCC accounts for 3% of all malignant tumors and now
Prognostic Value of Thrombocytosis in Renal Cell Carcinoma Karim Bensalah, Emmanuelle Leray, Patricia Fergelot, Nathalie Rioux-Leclercq, Jacques Tostain, François Guillé and Jean-Jacques Patard* From the
More informationGebruik van predictieve markers voor targeted therapy in de algemene praktijk
Gebruik van predictieve markers voor targeted therapy in de algemene praktijk Gerrit A. Meijer, MD, PhD Professor of Pathology Chair of the Department of Pathology VU Universtiy Medical Center Amsterdam
More informationIl percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
More informationEndoscopic Therapy for Early Esophageal Cancer: EMR and ESD
Endoscopic Therapy for Early Esophageal Cancer: EMR and ESD AATS Toronto April 26, 2014 Lorenzo Ferri MD PhD David S. Mulder Chair in Surgery Associate Professor of Surgery and Oncology Disclosures Olympus
More information<1 cm WDT-UMP, FT-UMP. Kakudo K et al, Pathol Int,2009, Endocr J, 2011 and Pathol Int, 2012
More information
Article in press - uncorrected proof
Clin Chem Lab Med 2009;47(9):1133 1139 2009 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2009.253 2009/260 Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue
More informationHow to treat early gastric cancer. Surgery
How to treat early gastric cancer Surgery Mark I. van Berge Henegouwen Department of Surgery, AMC, Amsterdam Director upper GI surgical unit Academic Medical Center Upper GI surgery at AMC 100 oesophagectomies
More informationEndoscopic Submucosal Dissection (E.S.D.) vs. Endoscopic Mucosal Resection (E.M.R.) in Colombia. Advocating E.M.R.
Controversies in Gastroenterology Endoscopic Submucosal Dissection (E.S.D.) vs. Endoscopic Mucosal Resection (E.M.R.) in Colombia. Advocating E.M.R. Raúl Cañadas Garrido, MD. 1 1 Internist-Gastroenterologist.
More informationUitgangsvraag 3: Welke prognostische factoren moeten er beschreven worden in het pa-verslag van het resectiepreparaat
Uitgangsvraag 3: Welke prognostische factoren moeten er beschreven worden in het pa-verslag van het resectiepreparaat van HCC patiënten? Primaire studies I Study ID II Method III Patient characteristics
More informationGünter Klöppel Dept. of Pathology Consultation Center for Pancreatic and Endocrine tumors Technische Universität München
Günter Klöppel Dept. of Pathology Consultation Center for Pancreatic and Endocrine tumors Technische Universität München Incidental 1.5 cm tumor in a 45-year old man: Most probable diagnosis - Pan NEN.
More informationRecommendations for the Reporting of Pleural Mesothelioma
Recommendations for the Reporting of Pleural Mesothelioma Association of Directors of Anatomic and Surgical Pathology * DOI: 10.1309/6A30YQHBMTHEJTEM It has been evident for decades that pathology reports
More informationHistopathology of Colorectal Cancer after Neoadjuvant Chemoradiation Therapy
The Open Pathology Journal, 2009, 3, 91-98 91 Open Access Histopathology of Colorectal Cancer after Neoadjuvant Chemoradiation Therapy Maura O Neil * and Ivan Damjanov Department of Pathology and Laboratory
More informationThe Royal Marsden. Surgery for Gastric and GE Junction Cancer: primary palliative where and when? William Allum
The Royal Marsden Surgery for Gastric and GE Junction Cancer: primary palliative where and when? William Allum Any surgeon can cure Surgeon - dependent No surgeon can cure EMR D2 GASTRECTOMY H N SN. WEDGE
More informationStomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda
Stomach (Gastric) Cancer Prof. M K Mahajan ACDT & RC Bathinda Gastric Cancer Role of Radiation Layers of the Stomach Mucosa Submucosa Muscularis Serosa Stomach and Regional Lymph Nodes Stomach and Regional
More informationA New Biomarker in Prostate Cancer Care: Oncotype Dx. David M Albala, MD Chief of Urology Crouse Hospital Syracuse, NY
A New Biomarker in Prostate Cancer Care: Oncotype Dx David M Albala, MD Chief of Urology Crouse Hospital Syracuse, NY Learning Objectives Review the current challenges in the prediction and prognosis of
More informationThe Staging of Colorectal Cancer: What s New in the Seventh Edition of The AJCC Cancer Staging Manual
The Staging of Colorectal Cancer: What s New in the Seventh Edition of The AJCC Cancer Staging Manual J. Milburn Jessup, MD Chief, Diagnostics Evaluation Branch Cancer Diagnosis Program, DCTD National
More informationTHYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
More informationNancy E. Davidson, MD Johns Hopkins University. Breast Cancer
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationInflammatory Breast Cancer: A Unique Pathologic Entity?
Inflammatory Breast Cancer: A Unique Pathologic Entity? Sandra M. Swain, M.D. Director, Washington Cancer Institute Washington Hospital Center Washington DC Outline Overview Therapy High dose chemotherapy
More informationCaptivator EMR Device
Device Clinical Article and Abstract Summary Endoscopic Mucosal Bergman et al: EMR Training Tips Bergman et al: EMR Learning Curve ASGE: EMR & ESD Guidelines Bergman et al: Captivator EMR vs Cook Duette
More informationHAVE YOU BEEN NEWLY DIAGNOSED with DCIS?
HAVE YOU BEEN NEWLY DIAGNOSED with DCIS? Jen D. Mother and volunteer. Diagnosed with DCIS breast cancer in 2012. An educational guide prepared by Genomic Health This guide is designed to educate women
More informationStadards in Abdominoperineal Resection
Stadards in Abdominoperineal Resection Manuel Francisco T. Roxas, MD, FPCS, FPSCRS, FACS Clinical Associate Professor, University of the Philippines Chief, Section of Colorectal Surgery, Department of
More informationHistorical Basis for Concern
Androgens After : Are We Ready? Mohit Khera, MD, MBA Assistant Professor of Urology Division of Male Reproductive Medicine and Surgery Scott Department of Urology Baylor College of Medicine Historical
More informationPET/CT in Lung Cancer
PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT
More informationTitle: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma
Author's response to reviews Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma Authors: Tanner L Bartholow (bartholow.tanner@medstudent.pitt.edu) Uma R Chandran (chandranur@msx.upmc.edu)
More informationMale Breast Cancer. Abstract
Male Breast Cancer N. Kayani,M. N. Khan,Y. Bhurgri,S. Gill,M. I. Nasir ( The Aga Khan University Medical Center. Karachi. ) T. Siddiqui ( Departments of Pathology and Medicine, The Aga Khan University,
More informationTargeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
More informationMesothelioma. Malignant Pleural Mesothelioma
Mesothelioma William G. Richards, PhD Brigham and Women s Hospital Malignant Pleural Mesothelioma 2,000-3,000 cases per year (USA) Increasing incidence Asbestos (50-80%, decreasing) 30-40 year latency
More informationPROSPETTIVE FUTURE NEL TRATTAMENTO. Cinzia Ortega Dipartimento di Oncologia Medica Fondazione del Piemonte per l Oncologia I.R.C.C.S.
PROSPETTIVE FUTURE NEL TRATTAMENTO MEDICO DEL mrcc Cinzia Ortega Dipartimento di Oncologia Medica Fondazione del Piemonte per l Oncologia I.R.C.C.S. Candiolo Future strategies in mrcc Improve therapeutic
More informationChapter 2. Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands.
Chapter 2 Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: a population-based study in the Netherlands. Wendy Kelder 1,2, Bas Inberg 2, Michael Schaapveld 3, Arend
More informationPrinciples of Radiation Therapy A Bapsi Chakravarthy, MD Associate e P rofessor Professor Radiation Oncology
Principles of Radiation Therapy A Bapsi Chakravarthy, MD Associate Professor Radiation Oncology Disclosure Information I have no financial relationships to disclose relevant to the conten of this presentation.
More informationImpact of radiation therapy on survival in patients with triple negative breast cancer
548 Impact of radiation therapy on survival in patients with triple negative breast cancer LAUREN T. STEWARD 1, FENG GAO 2, MARIE A. TAYLOR 3 and JULIE A. MARGENTHALER 1 1 Department of Surgery; 2 Division
More informationThe Diagnosis of Cancer in the Pathology Laboratory
The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens
More informationPrognostic and Predictive Factors in Breast Cancer Kyle T. Bradley, MD, MS CAP Cancer Committee
Prognostic and Predictive Factors in Breast Cancer Kyle T. Bradley, MD, MS CAP Cancer Committee Breast cancer is the most common malignant tumor in American women and is second only to lung cancer as a
More informationOutline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
More informationIntraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas
International Urology and Nephrology 28 (1), pp. 73-77 (1996) Intraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas $. O. OZDAMAR,*
More informationMRI in Rectal Cancer. Kartik S Jhaveri, MD,FRCPC Director, Abdominal MRI Director, CME Program
MRI in Rectal Cancer Kartik S Jhaveri, MD,FRCPC Director, Abdominal MRI Director, CME Program DISCLOSURES No Relevant Disclosures 2 OBJECTIVES Imaging of Rectal Cancer Why MRI? MR Protocol MR Anatomy Preoperative
More informationNeoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Catania
Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Neoplasia gastrica cistica: GIST o leiomiosarcoma? Aims of presentation Atypical
More informationHER2 Status: What is the Difference Between Breast and Gastric Cancer?
Ask the Experts HER2 Status: What is the Difference Between Breast and Gastric Cancer? Bharat Jasani MBChB, PhD, FRCPath Marco Novelli MBChB, PhD, FRCPath Josef Rüschoff, MD Robert Y. Osamura, MD, FIAC
More informationIntegrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases
I Congresso de Oncologia D Or July 5-6, 2013 Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases Michael A. Choti, MD, MBA, FACS Department of Surgery Johns Hopkins University
More informationThursday, November 3, 2005
Thursday, November 3, 2005 8:30-10:30 a. m. Gastric Tumors, Session 1 Chairman: P. Ruszniewski, Clichy, France 9:00-9:30 a. m. Working Group Sessions Pathology and Genetics Group leaders: G. Rindi, Parma,
More information7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Melanoma of Skin. Overview. This webinar is sponsored by
AJCC 7 th Edition Staging Melanoma of Skin Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers
More informationCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Now and the Future Mazin Al-kasspooles, MD Associate Professor of Surgery Division of Surgical Oncology Director, Regional Therapy
More informationPrognostic factors in locally advanced prostate cancer as determined by biochemistry, imaging studies and pathology
Prognostic factors in locally advanced prostate cancer as determined by biochemistry, imaging studies and pathology Authors Key words C.Y. Hsu, S. Joniau, R. Oyen, T. Roskams, H. Van Poppel Prognostic
More informationRenal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD
Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD Department of Pathology University of Szeged, Hungary ISUP Vancouver Classification of Renal Neoplasia Am J Surg Pathol 37:14691489, 2013 13 histologic
More informationThe 4Kscore blood test for risk of aggressive prostate cancer
The 4Kscore blood test for risk of aggressive prostate cancer Prostate cancer tests When to use the 4Kscore Test? Screening Prior to 1 st biopsy Prior to negative previous biopsy Prognosis in Gleason 6
More informationProstate Cancer. Treatments as unique as you are
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
More informationHepatocellular Carcinoma: What the hepatologist wants to know
Hepatocellular Carcinoma: What the hepatologist wants to know Hélène Castel, MD Liver Unit Hôpital St-Luc CHUM? CAR Annual Scientific Meeting Saturday, April 27 th 2013 Disclosure statement I do not have
More informationPrognostic Factors for Triple-Negative Breast Cancer Patients Receiving Preoperative Systemic Chemotherapy
Original Study Prognostic Factors for Triple-Negative Breast Cancer Patients Receiving Preoperative Systemic Chemotherapy Sota Asaga, Takayuki Kinoshita, Takashi Hojo, Junko Suzuki, Kenjiro Jimbo, Hitoshi
More informationA918: Prostate: adenocarcinoma
A918: Prostate: adenocarcinoma General facts of prostate cancer The prostate is about the size of a walnut. It is just below the bladder and in front of the rectum. The tube that carries urine (the urethra)
More informationSurvival analysis of 220 patients with completely resected stage II non small cell lung cancer
窑 Original Article 窑 Chinese Journal of Cancer Survival analysis of 22 patients with completely resected stage II non small cell lung cancer Yun Dai,2,3, Xiao Dong Su,2,3, Hao Long,2,3, Peng Lin,2,3, Jian
More informationImage. 3.11.3 SW Review the anatomy of the EAC and how this plays a role in the spread of tumors.
Neoplasms of the Ear and Lateral Skull Base Image 3.11.1 SW What are the three most common neoplasms of the auricle? 3.11.2 SW What are the four most common neoplasms of the external auditory canal (EAC)
More informationUpdate on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
More informationCANCER TREATMENT PROGRAM
CANCER TREATMENT PROGRAM - Annual Report - An affiliation between Central Washington Hospital & Wenatchee Valley Medical Center 2013 Cancer Treatment Program at Confluence Health 2 Confluence Health Affiliation
More informationRobert Bristow MD PhD FRCPC
Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research
More informationLymph Nodes and Cancer What is the lymph system?
Lymph Nodes and Cancer What is the lymph system? Our bodies have a network of lymph vessels and lymph nodes. (Lymph is pronounced limf.) This network is a part of the body s immune system. It collects
More informationRectal Cancer. To Radiate or not to radiate? Q: Should rectal cancer RT/CRT decisions be based solely on stage? 11/09/2014
Rectal Cancer To Radiate or not to radiate?? Dr. Corinne Doll Radiation Oncologist Tom Baker Cancer Centre Calgary, Alberta Q: Should rectal cancer RT/CRT decisions be based solely on stage? 1 Q: Can RT/CRT
More informationPancreatic Cancer. The Killer that must be discovered early. Dr Alfred Kow Wei Chieh
Pancreatic Cancer The Killer that must be discovered early 27 th June 2015 Dr Alfred Kow Wei Chieh Consultant Department of Surgery Division of HPB Surgery & Liver Transplantation & Assistant Dean (Education)
More informationLung Cancer Treatment Guidelines
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
More informationBreast Cancer. The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer.
Breast Cancer What Does the Pathology Report Say Normal Cells The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer. Non-Invasive
More informationKomorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
More informationAdiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka
Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka Neoadiuvant and adiuvant therapy for advanced gastric cancer Franco Roviello, IT Neoadjuvant and adjuvant therapy for advanced
More informationProtocol for the Examination of Specimens From Patients With Malignant Pleural Mesothelioma
Protocol for the Examination of Specimens From Patients With Malignant Pleural Mesothelioma Based on AJCC/UICC TNM, 7th edition Protocol web posting date: February 1, 2011 Procedures Resection Authors
More informationLuis D. Carcorze Soto, MD PGY-3
Luis D. Carcorze Soto, MD PGY-3 Peritoneal Surface Malignancies Peritoneum Patient Selection Operative Technique HIPEC EPIC Primary: Primary Peritoneal Carcinoma Malignant Peritoneal Mesothelioma Metastatic:
More informationNational Bowel Cancer Audit Report 2008 Public and Executive Summary
National Bowel Cancer Audit Report 2008 Public and Executive Summary Prepared in association with: Healthcare Quality Improvement Partnership HQIP Association of Coloproctology of Great Britain and Ireland
More informationEnsemble Learning of Colorectal Cancer Survival Rates
Ensemble Learning of Colorectal Cancer Survival Rates Chris Roadknight School of Computing Science University of Nottingham Malaysia Campus Malaysia Chris.roadknight@nottingham.edu.my Uwe Aickelin School
More informationThe Pathological Assessment of Total Mesorectal Excision: What Are the Relevant Resection Margins?
The Pathological Assessment of Total Mesorectal Excision: What Are the Relevant Resection Margins? Frank Autschbach F. Autschbach ( ) Institute of Pathology, Heidelberg University, Im Neuenheimer Feld
More information